Here, we found that overexpressing RIOK2 elevated the expression of N‐cadherin, β‐catenin, Twist1, fibronectin and ZEB‐1, whereas the miR‐4744 mimics treatment showed the opposite effects in glioma cells. The gene discussed is RIOK2; the disease is central nervous system cancer.